Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-002472
Filing Date
2020-03-12
Accepted
2020-03-12 07:22:00
Documents
90
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K trvn-20191231x10k.htm 10-K 3005799
2 EX-4.6 trvn-20191231ex4665ae87c.htm EX-4.6 30154
3 EX-23.1 trvn-20191231ex2310a6048.htm EX-23.1 10260
4 EX-31.1 trvn-20191231ex31168ffd7.htm EX-31.1 19101
5 EX-31.2 trvn-20191231ex3127c6296.htm EX-31.2 18790
6 EX-32.1 trvn-20191231ex3214cef59.htm EX-32.1 8776
7 EX-32.2 trvn-20191231ex322ecd363.htm EX-32.2 8837
8 GRAPHIC trvn20191231x10k001.jpg GRAPHIC 30241
  Complete submission text file 0001558370-20-002472.txt   11158455

Data Files

Seq Description Document Type Size
9 EX-101.INS trvn-20191231.xml EX-101.INS 2510858
10 EX-101.SCH trvn-20191231.xsd EX-101.SCH 63011
11 EX-101.CAL trvn-20191231_cal.xml EX-101.CAL 90515
12 EX-101.DEF trvn-20191231_def.xml EX-101.DEF 234781
13 EX-101.LAB trvn-20191231_lab.xml EX-101.LAB 657728
14 EX-101.PRE trvn-20191231_pre.xml EX-101.PRE 487331
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36193 | Film No.: 20707150
SIC: 2834 Pharmaceutical Preparations